Fibrosis: Oncodesign and TiumBio sign collaboration agreement for R&D of drug candidates
Under this agreement, Oncodesign will be responsible for identification, chemical synthesis and optimization of Nanocyclix® drug candidates and their early-stage analysis, while TiumBio will be responsible for the advanced evaluation of fibrotic efficacy of the drug candidates. This initial phase of the collaboration will be funded by TiumBio.
[EN] When your studies meet Good Laboratory Practices!
Home . Resources . [EN] When your studies meet Good Laboratory Practices!
Since 2018, the site of Oncodesign, located in the South of Paris, has been certified Good Laboratory Practices (GLP) by the French regulatory authorities (ANSM).
Our scientists develop, validate and perform your regulatory bioanalysis studies, in a quality environment and in accordance with Good Laboratory Practices. Our quality management system, under the responsibility of the BU Service Quality Assurance Manager, ensures the highest level of regulatory compliance along with the reliability and integrity of your experimental data. We carefully follow the guidelines for industry in a spirit of continuous quality improvement.
Our commitment, in line with our values, is to provide high quality services.